**Core Concept**
Long-acting insulin analogs are designed to provide a steady, basal level of insulin throughout the day and night, mimicking the body's natural insulin production. These insulins are characterized by their slow onset and long duration of action, typically lasting 24 hours or more.

**Why the Correct Answer is Right**
Insulin glargine is a long-acting insulin analog that is designed to provide a steady, basal level of insulin throughout the day and night. It has a slow onset of action, typically taking several hours to reach peak levels, and a long duration of action, lasting 24 hours or more. This allows for once-daily dosing and helps to mimic the body's natural insulin production. Insulin glargine is absorbed slowly into the bloodstream, where it is bound to insulin-like growth factor-1 (IGF-1) receptors, which reduces its clearance and prolongs its action.

**Why Each Wrong Option is Incorrect**
**Option B:** Insulin lispro is a rapid-acting insulin analog that begins to work within 15 minutes of injection, peaks in 1 hour, and has a short duration of action, typically lasting 2-4 hours. It is not suitable for basal insulin coverage.
**Option C:** Insulin aspart is another rapid-acting insulin analog that has a similar pharmacokinetic profile to insulin lispro. It is not designed for long-term basal insulin coverage.
**Option D:** Insulin glulisine is also a rapid-acting insulin analog that is similar to insulin lispro and aspart in terms of its pharmacokinetic profile. It is not suitable for long-term basal insulin coverage.

**Clinical Pearl / High-Yield Fact**
It's essential to note that long-acting insulin analogs like insulin glargine should not be used to correct high blood glucose levels, as they take several hours to reach peak levels. Rapid-acting or short-acting insulins should be used instead to correct high blood glucose levels.

**✓ Correct Answer: A. Insulin glargine**